Question 1

What is the catalog number for CGP 52432?

Accepted Answer

The catalog number for CGP 52432 is orb1222716.

Question 2

What sizes are available for CGP 52432?

Accepted Answer

CGP 52432 is available in the following size(s): 200 mg, 500 mg, 1 g, 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does CGP 52432 come in?

Accepted Answer

CGP 52432 is available in 9 different pack sizes.

Question 4

Is CGP 52432 in stock?

Accepted Answer

CGP 52432 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is CGP 52432 used for?

Accepted Answer

Cgp 52432 is a GABA-A receptor antagonist.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 7

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 8

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

CGP 52432

Product Specifications

CAS Number

Product Name Alternative

Purity

Solubility

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Other Product Names

Available Sizes

Frequently Asked Questions

Explore Other Products

Lentiviral human HHLA1 shRNA (UAS) - Lentiviral human HHLA1 shRNA (UAS, RFP) (25)

OVCH1, NT (OVCH1, Ovochymase-1) (Biotin) discontinued

Recombinant Human PIK3R1/PI3-kinase p85-alpha, N-His

Recombinant Human PIK3R1/PI3-kinase p85-alpha, N-His

Recombinant Human PIK3R1/PI3-kinase p85-alpha, N-His

Reagecon Iodoplatinate Reagent according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)